Open Access

This article has an erratum: [erratum]

Med Buccale Chir Buccale
Volume 16, Number 2, avril 2010
Page(s) 79 - 84
Section Articles originaux / Original articles
Published online 07 April 2010
  1. Prescrire Rédaction. L’anesthésie locale dentaire avec vasoconstricteur. Une faible dose d’adrénaline est utile et sans contre-indication cardiovasculaire. Rev Prescrire 2003;23:371-6
  2. Daimellah F, Issad MS, Boukais H. Zerrouki W, Berkane M, Lehachi S, Bennoui Z, Khelil S, Hannoun D, Abrouk S. Avulsions dentaires chez les patients cardiaques traités par les anticoagulants : résultats d’un essai thérapeutique acénocoumarol versus héparine calcique. Med Buc Chir Buc 2009;15 63-74. [CrossRef] [EDP Sciences]
  3. Sveen K. Effect of addition of a vasoconstrictor to local anesthesic solution on operative and postoperative bleeding, analgesia and woundhealing. Int Oral Surg 1979;8:301-6. [CrossRef]
  4. Rahn R, Hauzeneder W, Flanze L. Wirksamkeit einer zweiprozentigen, adrenalinfreien Articain-Lösung (Ultracain 2%) zur zahnärztlichen Lokalanästhesie. Dtsch Stomatol 1991;41:379-82. [PubMed]
  5. Daublander M, Muller R, Lipp MDW. The incidence of complications associeted with local anesthesia in dentistry. Anesth Prog 1997;44:132-41. [PubMed]
  6. Malamed SF, Gagnon S, Leblanc D. Articaine hydrochloride : a study of the safety of a new amide local anesthesic. J Am Dent Assoc 2001;132:177-85. [PubMed]
  7. Blinder D, Manor Y, Shemesh J, Taicher S. Electrocardiographic changes in cardiac patients having dental extractions under a local anesthetic containing a vasopressor. J Oral Maxillofac Surg 1998;56:1399-402. [CrossRef] [PubMed]
  8. Niwa H, Sugimura M, Satoh Y, Tanimoto A. Cardiovascular response to epinephrine-containing local anesthesia in patients with cardiovascular disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:610-6. [CrossRef] [PubMed]
  9. Elad S, Admon D, Kedmi M, Naveh E, Benzki E, Ayalon S, Tuchband A, Lutan H, Kaufman E. The cardiovascular effect of local anesthesia with articaine plus 1:200,000 adrenalin versus lidocaine plus 1:100,000 adrenalin in medically compromised cardiac patients: a prospective, randomized, double blinded study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:725-30. [CrossRef] [PubMed]
  10. Bader JD, Bonito AJ, Shugars DA. Cardiovascular effects of Epinephrine in hypertensive dental patients. Evidence report/Technology assessment N˚48, Agency for Health Research and Quality. July 2002.
  11. Cintron G, Medina R, Reyes AA, Lyman G. Cardiovascular effects and safety of dental anesthesia and dental interventions in patients with recent uncomplicated myocardial infarction. Arch Intern Med 1986;146:2203-4. [CrossRef] [PubMed]
  12. Neves RS, Neves IL, Artiga Giorgi DM, Grupi CJ, Cesar LA, Hueb W, Grinberg M. Effets of Epinephrine in local dental anesthesia in patients with coronary artery disease. Arq Braz Cardiol 2007;88:482-7.
  13. Conrado VC, de Andrade J, de Angelis GA, de Andrade AC, Timerman L, Andrade MM, Moreira DR, Sousa AG, Sousa JE, Piegas LS. Cardiovascular effects of local anesthesia with vasoconstrictor during dental extraction in coronary patients. Arq Bras Cardiol 2007;88:507-13. [PubMed]
  14. Laragnoit AB, Neves RS, Neves IL, Vieira JE. Locoregional anesthesia for dental treatment in cardiac patients: a comparative study of 2% plain lidocaine and 2% lidocaine with epinephrine (1:100,000). Clinics 2009;64:177-82. [PubMed]
  15. Recommandations de la Société Francophone de Médecine Buccale et Chirurgie Buccale. Emploi des vasoconstricteurs en odonto-stomatologie. Med Buc Chir Buc 2003;9:65-94

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.